MarketResearch.Biz delivers in-depth insights on the global neuroprotective products market in its upcoming report titled, “Global Neuroprotective Products Market Trends, Applications, Analysis, Growth, and Forecast to 2027”. The global neuroprotective products market is estimated to register a CAGR of X.X% in terms of value during forecast period 2018–2027. The report offers in-depth insights, revenue details, and other vital information regarding the global neuroprotective products market, and the various trends, drivers, restraints, opportunities, and threats in the target market till 2027. The report offers insightful and detailed information regarding the various key players operating in the global neuroprotective products market, their financials, supply chain trends, technological innovations, key developments, apart from future strategies, acquisitions & mergers, and market footprint. The global neuroprotective products market report has been segmented on the basis treatment of medical condition, end-user, and region.
Neurodegeneration is the progressive loss of structure or function of neurons, including death of neurons. Many neurodegenerative diseases including amyotrophic lateral sclerosis, Parkinson's, Alzheimer's, and Huntington's occur as a result of neurodegenerative processes. Moreover, neurodegenerative diseases and their prevalence increases significantly with increasing age. Neuroprotective products are medications that protect the brain neurons from degeneration and injury and are used in the treatment of several central nervous system complications such as Parkinson's disease, Alzheimer's disease, and traumatic brain injuries among others.
Increasing incidence of neurodegenerative diseases across the globe is a key factor driving growth of the global neuroprotective products market. In addition, increasing prevalence of neurodegenerative diseases with aging, increasing demand for medications to treat the symptoms related to severe neuron dysfunction, and rising need for effective treatments for brain and trauma injuries are major factors expected to drive growth of the global neuroprotective products market over the forecast period.
However, high costs involved in R&D of neuroprotective drugs is a key factor restraining growth of the global neuroprotective products market. Additionally, stringent regulatory standards, and high failure rate of clinical trials are other factors expected to restrain growth of the global neuroprotective products market over the forecast period.
North America is estimated to account for largest market share in terms of revenue as compared to that of markets in other regions. This is attributed to high awareness about neurodegeneration, and neuroprotective products in the region. Europe is estimated to account for second largest revenue share contribution to the global market followed by markets in Asia Pacific. The markets in Europe and Asia Pacific are expected to have an increasing demand for neuroprotective products, due to commercialization of different personalized medications for neurodegenerative disorders in these regions over the forecast period.
Global Neuroprotective Products Market Segmentation:
Global neuroprotective products market segmentation by treatment of medical conditions:
- Alzheimer's disease
- Multiple sclerosis
- Parkinson's disease
- Ocular degeneration (retinal disorders)
- Amyotrophic lateral sclerosis (ALS)
- Huntington's disease
- Brain injury
- Other disorders affecting the nervous system
Global neuroprotective products market segmentation by end user:
- Medical Centers
Global neuroprotective products market segmentation by region:
- North America
- Asia Pacific
- Latin America
- Middle East & Africa
Attribute Report Details Market Size Ask For Market Size Growth Rate Ask For Growth Rate Key Companies Ask For Companies Report Coverage Revenue analysis, Competitive landscape, Key company analysis, Market Trends, Key segments, Distribution Channel, Market Dynamics, COVID-19 Impact Analysis and more… Historical Data Period 2015-2020 Base Year 2022 Forecast Period 2022-2031 Region Scope North America, Europe, Asia-Pacific, South America, Middle East & Africa Country Scope United States, Canada and Mexico, Germany, France, UK, Russia and Italy, China, Japan, Korea, India and Southeast Asia, Brazil, Argentina, Colombia etc.Saudi Arabia, UAE, Egypt, Nigeria and South Africa Revenue in US$ Mn
- Genervon Biopharmaceuticals
- NeuroVive Pharmaceutical AB
- BHRPharma LLC
- Neuren Pharmaceuticals
- Allon therapeutics Inc.
- Bionure Inc.
Request for TOC
Why Choose Us
- 360 Degree Approach
- Growth Consulting
- 24/7 Research Support
- Comprehensive-Level of Customization
- Comprehensive-Level of Customization
- Competitive Intelligence
- Single-Country/ Region Intelligence
- Post-Sale Service Assistance
- Access to Lead Analysts
- Available in PDF, Excel, Word/ PPT
Request for Customization
Don't just take our word. We are trusted by these great companies!